|
1.
|
|
5.3 MB |
Impacte de la COVID-19 en les famílies de pacients pediàtrics trasplantats d'òrgan sòlid
/
Forner Puntonet, Mireia ;
Gisbert Gustemps, Laura, dir. ;
Ramos-Quiroga, Josep Antoni, dir.
El trasplantament d'òrgan sòlid (TOS) constitueix el tractament d'elecció en un gran nombre de malalties pediàtriques renals, hepàtiques, cardíaques o pulmonars en fase terminal. Aquest procediment quirúrgic suposa un canvi d'una malaltia que posa en perill la vida a una condició de salut crònica, contribuint a perllongar la supervivència dels pacients. [...]
El trasplante de órgano sólido (TOS) constituye el tratamiento de elección en un gran número de enfermedades pediátricas renales, hepáticas, cardíacas o pulmonares en fase terminal. Este procedimiento quirúrgico supone un cambio de una enfermedad que pone en peligro la vida a una condición de salud crónica, contribuyendo a prolongar la supervivencia de los pacientes. [...]
Solid organ transplantation (SOT) is the treatment of choice in a large number of end-stage pediatric kidney, liver, heart or lung diseases. This surgical procedure represents a change from a life-threatening disease to a chronic health condition, contributing to prolonging the survival of patients. [...]
2023
|
|
|
2.
|
|
10 p, 712.3 KB |
Shared decision making in patients with substance use disorders : A one-year follow-up study
/
Serrano-Pérez, Pedro (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Rivero-Santana, Amado (Fundación Canaria Instituto de Investigación Sanitaria de Canarias) ;
Daigre, Constanza (Hospital Universitari Vall d'Hebron) ;
Palma-Álvarez, Raúl Felipe (Hospital Universitari Vall d'Hebron) ;
Nistal-Franco, Icía (Hospital Álvaro Cunqueiro (Vigo)) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Grau-López, Lara (Hospital Universitari Vall d'Hebron)
Patient-centered care in therapeutic processes has been associated with better clinical outcomes, however, it remains a poorly studied aspect in Substance Use Disorder (SUD). The study aimed to evaluate patient's preferences, perceived participation in treatment decisions and activation level; and how they predict retention, pharmacological adherence and substance use during one-year follow-up. [...]
2023 -  10.1016/j.psychres.2023.115540
Psychiatry research, Vol. 329 (2023) , p. 115540
|
|
|
3.
|
|
3 p, 97.3 KB |
Corrigendum : Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: differences between males and females
/
Serra-Navarro, Maria (Hospital Clínic i Provincial de Barcelona) ;
Amoretti, Silvia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Verdolini, Norma (Hospital Clínic i Provincial de Barcelona) ;
Forte, Maria Florencia (Hospital Clínic i Provincial de Barcelona) ;
Sánchez-Torres, Ana M. (Instituto de Investigación Sanitaria de Navarra) ;
Vieta, Eduard (Hospital Clínic i Provincial de Barcelona) ;
Clougher, Derek (Hospital Clínic i Provincial de Barcelona) ;
Lobo, Antonio (Instituto de Investigación Sanitaria Aragón) ;
González-Pinto, Ana (Universidad del País Vasco) ;
Panadero, Rocío (Hospital General Universitario Gregorio Marañón) ;
Roldán, Alexandra (Institut d'Investigació Biomèdica Sant Pau) ;
Carvalho, André F. (Deakin University) ;
de la Serna, Elena (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Toll, Alba (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Torrent, Carla (Hospital Clínic i Provincial de Barcelona) ;
Cuesta, Manuel J. (Instituto de Investigación Sanitaria de Navarra) ;
Bernardo, Miquel (Hospital Clínic i Provincial de Barcelona)
Deficits in psychosocial functioning are present in the early stages of psychosis. Several factors, such as premorbid adjustment, neurocognitive performance, and cognitive reserve (CR), potentially influence functionality. [...]
2023 - 10.3389/fpsyt.2023.1200313
Frontiers in psychiatry, Vol. 14 (june 2023)
|
|
|
4.
|
|
14 p, 902.2 KB |
Attention-deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases : A systematic review and meta-analysis
/
Li, Lin (Karolinska Institutet (Estocolm, Suècia)) ;
Garcia-Argibay, Miguel (Örebro University) ;
Du Rietz, Ebba (Karolinska Institutet (Estocolm, Suècia)) ;
Brikell, Isabell (Aarhus University) ;
Solmi, Marco (University of Southampton) ;
Cortese, Samuele (University of Nottingham) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ribasés Haro, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Chang, Zheng (Karolinska Institutet (Estocolm, Suècia)) ;
Larsson, Henrik (Karolinska Institutet (Estocolm, Suècia)) ;
Yao, Honghui (Karolinska Institutet (Estocolm, Suècia)) ;
Zhang, Le (Karolinska Institutet (Estocolm, Suècia)) ;
Universitat Autònoma de Barcelona
Attention-deficit/hyperactivity disorder (ADHD) often co-occurs with other psychiatric and physical diseases. However, available evidence on associations between ADHD and cardiovascular diseases (CVDs) is mixed. [...]
2023 - 10.1002/jcv2.12158
JCPP Advances, Vol. 3 (april 2023)
|
|
|
5.
|
|
10 p, 1.9 MB |
Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan
/
Vilar-Ribó, L (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Cabana-Domínguez, Judit (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martorell, Lourdes (Universitat Rovira i Virgili) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sanchez-Roige, Sandra (Vanderbilt University Medical Center) ;
Palmer, Abraham A. (Vanderbilt University Medical Center) ;
Vilella, Elisabet (Hospital Universitari Institut Pere Mata) ;
Ribasés Haro, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Muntané, Gerard (Universitat Pompeu Fabra) ;
Soler Artigas, María (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
There is evidence linking ADHD to a reduced life expectancy. The mortality rate in individuals with ADHD is twice that of the general population and it is associated with several factors, such as unhealthy lifestyle behaviors, social adversity, and mental health problems that may in turn increase mortality rates. [...]
2023 - 10.1038/s41386-023-01555-x
Neuropsychopharmacology, Vol. 48 (march 2023) , p. 981-990
|
|
|
6.
|
|
9 p, 2.7 MB |
Genetic association study of childhood aggression across raters, instruments, and age
/
Ip, Hill F. (Vrije Universiteit Amsterdam) ;
van der Laan, Camiel M. (Netherlands Institute for the Study of Crime and Law Enforcement) ;
Krapohl, Eva M. L. (King's College London) ;
Brikell, Isabell (Karolinska Institutet (Estocolm, Suècia)) ;
Sánchez-Mora, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Nolte, Ilja M. (University of Groningen) ;
Pourcain, Beate St (Radboud University) ;
Bolhuis, Koen (Erasmus University Medical Center) ;
Palviainen, Teemu (University of Helsinki) ;
Zafarmand, Hadi (University of Amsterdam) ;
Colodro-Conde, Lucía (QIMR Berghofer Medical Research Institute (Brisbane, Austràlia)) ;
Gordon, Scott D (QIMR Berghofer Medical Research Institute (Brisbane, Austràlia)) ;
Zayats, Tetyana (Stanley Center for Psychiatric Research) ;
Aliev, Fazil (Karabuk University) ;
Jiang, Chang (University of Florida) ;
Wang, Carol A. (The University of Newcastle) ;
Saunders, Gretchen (University of Minnesota) ;
Karhunen, Ville (Imperial College London) ;
Hammerschlag, Anke R. (Amsterdam Public Health Research Institute) ;
Adkins, Daniel E. (University of Utah) ;
Border, Richard (University of Colorado Boulder) ;
Peterson, Roseann E. (Virginia Commonwealth University) ;
Prinz, Joseph A. (Duke University) ;
Thiering, Elisabeth (Ludwig-Maximilians-University of Munich) ;
Seppälä, Ilkka (Tampere University) ;
Vilor-Tejedor, Natàlia (Fundació Pasqual Maragall (FPM)) ;
Ahluwalia, Tarunveer Singh (Steno Diabetes Center Copenhagen) ;
Day, Felix R. (University of Cambridge School of Clinical Medicine) ;
Hottenga, Jouke Jan (Vrije Universiteit Amsterdam) ;
Allegrini, Andrea G. (King's College London) ;
Rimfeld, Kaili (King's College London) ;
Chen, Qi (Karolinska Institutet (Estocolm, Suècia)) ;
Lu, Yi (Karolinska Institutet (Estocolm, Suècia)) ;
Martin, Joanna (Cardiff University) ;
Soler Artigas, María (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rovira, Paula (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Bosch, Rosa (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Español-Martín, Gemma (Hospital Universitari Vall d'Hebron) ;
Ramos-Quiroga, Josep Antoni (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Neumann, Alexander (Jewish General Hospital) ;
Ensink, Judith (De Bascule, Academic Centre for Child and Adolescent Psychiatry) ;
Grasby, Katrina (QIMR Berghofer Medical Research Institute (Brisbane, Austràlia)) ;
Morosoli, José J. (QIMR Berghofer Medical Research Institute (Brisbane, Austràlia)) ;
Tong, Xiaoran (University of Florida) ;
Marrington, Shelby (The University of Queensland) ;
Middeldorp, Christel (Children's Health Queensland Hospital) ;
Scott, James G. (Queensland Centre for Mental Health Research) ;
Vinkhuyzen, Anna (University of Queensland) ;
Shabalin, Andrey A. (University of Utah) ;
Corley, Robin (University of Colorado Boulder) ;
Evans, Luke M. (University of Colorado Boulder) ;
Sugden, Karen (Duke University) ;
Alemany, Sílvia (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Sass, Lærke (University of Copenhagen) ;
Vinding, Rebecca (University of Copenhagen) ;
Ruth, Kate (University of Exeter Medical School) ;
Tyrrell, Jess (University of Exeter Medical School) ;
Davies, Gareth E. (Avera Institute for Human Genetics) ;
Ehli, Erik A. (Avera Institute for Human Genetics) ;
Hagenbeek, Fiona A. (Vrije Universiteit Amsterdam) ;
De Zeeuw, Eveline (Vrije Universiteit Amsterdam) ;
Van Beijsterveldt, Toos C.E.M. (Vrije Universiteit Amsterdam) ;
Larsson, Henrik (Orebro University) ;
Snieder, Harold (University of Groningen) ;
Verhulst, Frank C. (Copenhagen University Hospital) ;
Amin, Najaf (Erasmus University Medical Center) ;
Whipp, Alyce M. (University of Helsinki) ;
Korhonen, Tellervo (University of Helsinki) ;
Vuoksimaa, Eero (University of Helsinki) ;
Rose, Richard J. (Indiana University) ;
Uitterlinden, André G. (Netherlands Genomics Initiative (NGI)) ;
Heath, Andrew C. (Washington University) ;
Madden, Pamela (Washington University) ;
Haavik, Jan (Haukeland University Hospital (Bergen, Noruega)) ;
Harris, Jennifer R. (The Norwegian Institute of Public Health) ;
Helgeland, Øyvind (The Norwegian Institute of Public Health) ;
Johansson, Stefan E (University of Bergen) ;
Knudsen, Gun Peggy S. (The Norwegian Institute of Public Health) ;
Njolstad, Pal Rasmus (University of Bergen) ;
Lu, Qing (University of Florida) ;
Rodriguez, Alina (University of Lincoln) ;
Henders, Anjali K. (University of Queensland) ;
Mamun, Abdullah (University of Queensland) ;
Najman, Jackob M. (The University of Queensland) ;
Brown, Sandy (University of California) ;
Hopfer, Christian (University of Colorado School of Medicine) ;
Krauter, Kenneth (University of Colorado Boulder) ;
Reynolds, Chandra (University of California Riverside) ;
Smolen, Andrew (University of Colorado Boulder) ;
Stallings, Michael (University of Colorado Boulder) ;
Wadsworth, Sally (University of Colorado Boulder) ;
Wall, Tamara L. (University of California) ;
Silberg, Judy L. (Virginia Commonwealth University) ;
Miller, Allison (University of Otago Christchurch) ;
Keltikangas-Järvinen, Liisa (University of Helsinki) ;
Hakulinen, Christian (University of Helsinki) ;
Pulkki-Råback, Laura (University of Helsinki) ;
Havdahl, Alexandra (Norwegian Institute of Public Health) ;
Magnus, Per (Norwegian Institute of Public Health) ;
Raitakari, Olli T. (Turku University Hospital) ;
Perry, John R. B. (University of Cambridge School of Clinical Medicine) ;
Llop, Sabrina (Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Lopez-Espinosa, Maria-Jose (Universitat de València) ;
Bønnelykke, Klaus (University of Copenhagen) ;
Bisgaard, Hans (University of Copenhagen) ;
Sunyer Deu, Jordi (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Lehtimäki, Terho (Tampere University) ;
Arseneault, Louise (Duke University School of Medicine) ;
Standl, Marie (Helmholtz Zentrum München) ;
Heinrich, Joachim (University of Melbourne) ;
Boden, Joseph (University of Otago Christchurch) ;
Pearson, John (University of Otago Christchurch) ;
Horwood, L. John (University of Otago Christchurch) ;
Kennedy, Martin (University of Otago Christchurch) ;
Poulton, Richie (University of Otago) ;
Eaves, Lindon J. (Virginia Institute for Psychiatric and Behavioral Genetics) ;
Maes, Hermine H. (Virginia Commonwealth University) ;
Hewitt, John (University of Colorado Boulder) ;
Copeland, William E. (University of Vermont) ;
Costello, Elizabeth J. (Duke University) ;
Williams, Gail M. (The University of Queensland) ;
Wray, Naomi R (University of Queensland) ;
Järvelin, Marjo-Riitta (University of Oulu) ;
McGue, Matt (University of Minnesota) ;
Iacono, William (University of Minnesota) ;
Caspi, Avshalom (King's College London) ;
Moffitt, Terrie E. (King's College London) ;
Whitehouse, Andrew (The University of Western Australia) ;
Pennell, Craig E. (The University of Newcastle) ;
Klump, Kelly L. (Michigan State University) ;
Burt, S. Alexandra (Michigan State University) ;
Dick, Danielle M. (Virginia Commonwealth University) ;
Reichborn-Kjennerud, Ted (University of Oslo) ;
Martin, Nicholas G (QIMR Berghofer Medical Research Institute (Brisbane, Austràlia)) ;
Medland, Sarah Elizabeth (QIMR Berghofer Medical Research Institute (Brisbane, Austràlia)) ;
Vrijkotte, Tanja (University of Amsterdam) ;
Kaprio, Jaakko (University of Helsinki) ;
Tiemeier, Henning (Harvard TH Chan School of Public Health) ;
Smith, George Davey (University of Bristol) ;
Hartman, Catharina A. (University of Groningen) ;
Oldehinkel, Albertine J (University of Groningen) ;
Casas Brugué, Miquel (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Ribasés Haro, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lichtenstein, Paul (Karolinska Institutet (Estocolm, Suècia)) ;
Lundström, Sebastian (University of Gothenburg) ;
Plomin, Robert (King's College London) ;
Bartels, Meike (Amsterdam Public Health Research Institute) ;
Nivard, Michel G. (Vrije Universiteit Amsterdam) ;
Boomsma, Dorret I (Amsterdam Public Health Research Institute)
Childhood aggressive behavior (AGG) has a substantial heritability of around 50%. Here we present a genome-wide association meta-analysis (GWAMA) of childhood AGG, in which all phenotype measures across childhood ages from multiple assessors were included. [...]
2021 - 10.1038/s41398-021-01480-x
Translational psychiatry, Vol. 11 (july 2021)
|
|
|
7.
|
|
|
8.
|
|
9 p, 330.0 KB |
Attention deficit hyperactivity disorder symptoms and cannabis use after 1 year among students of the i-Share cohort
/
Jean, François Arnaud Matthieu (University of Bordeaux) ;
Arsandaux, Julie (University of Bordeaux) ;
Montagni, Ilaria (University of Bordeaux) ;
Collet, Ophélie (University of Bordeaux) ;
Fatséas, Mélina (University of Bordeaux) ;
Auriacombe, Marc (University of Bordeaux) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Côté, Sylvana M. (University of Montreal) ;
Tzourio, Christophe (University of Bordeaux) ;
Galéra, Cédric (University of Bordeaux) ;
Universitat Autònoma de Barcelona
Cannabis use in university students is associated with academic achievement failure and health issues. The objective of the study was to evaluate the association between attention deficit hyperactivity disorder (ADHD) symptoms and cannabis use after 1 year among students according to previous cannabis use. [...]
2022 - 10.1192/j.eurpsy.2022.14
European psychiatry, Vol. 65 (march 2022)
|
|
|
9.
|
|
14 p, 1.3 MB |
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
/
Sforzini, Luca (King's College London) ;
Worrell, Courtney (King's College London) ;
Kose, Melisa (King's College London) ;
Anderson, Ian M. (The University of Manchester and Manchester Academic Health Sciences Centre) ;
Aouizerate, Bruno (University of Bordeaux) ;
Arolt, Volker (University of Münster) ;
Bauer, Michael (University Hospital Carl Gustav Carus) ;
Baune, Bernhard T. (The University of Melbourne) ;
Cleare, Anthony J. (National Institute for Health Research Mental Health Biomedical Research Centre) ;
Cowen, Philip J. (University of Oxford) ;
Dinan, Timothy G. (University College Cork) ;
Fagiolini, Andrea (University of Siena) ;
Ferrier, I. Nicol (Newcastle University) ;
Hegerl, Ulrich (Goethe University) ;
Krystal, Andrew D. (Duke University School of Medicine) ;
Leboyer, Marion (Université Paris Est Creteil (UPEC)) ;
McAllister-Williams, R. Hamish (Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust) ;
McIntyre, Roger S. (Brain and Cognition Discovery Foundation) ;
Meyer-Lindenberg, Andreas (Heidelberg University) ;
Miller, Andrew H. (Emory University School of Medicine) ;
Nemeroff, Charles B. (University of Texas at Austin) ;
Normann, Claus (Medical Center - University of Freiburg) ;
Nutt, David (Imperial College) ;
Pallanti, Stefano (University of Florence) ;
Pani, Luca (VeraSci) ;
Penninx, Brenda W. J. H. (Vrije Universiteit and GGZinGeest) ;
Schatzberg, Alan F. (Stanford University) ;
Shelton, Richard C. (University of Alabama at Birmingham) ;
Yatham, Lakshmi N. (University of British Columbia) ;
Young, Allan H. (National Institute for Health Research Mental Health Biomedical Research Centre) ;
Zahn, Roland (National Institute for Health Research Mental Health Biomedical Research Centre) ;
Aislaitner, Georgios (Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM)) ;
Butlen-Ducuing, Florence (European Medicines Agency) ;
Fletcher, Christine (Biostatistics, GlaxoSmithKline) ;
Haberkamp, Marion (Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM)) ;
Laughren, Thomas (Laughren Psychopharm Consulting) ;
Mäntylä, Fanni-Laura (GAMIAN-Europe (Global Alliance of Mental Illness Advocacy Networks-Europe)) ;
Schruers, Koen (University of Leuven) ;
Thomson, Andrew (European Medicines Agency) ;
Arteaga-Henríquez, Gara (Hospital Universitari Vall d'Hebron) ;
Benedetti, Francesco (IRCCS Scientific Institute Ospedale San Raffaele) ;
Cash-Gibson, Lucinda (Hospital Universitari Vall d'Hebron) ;
Chae, Woo Ri (Charité - Universitätsmedizin Berlin) ;
De Smedt, Heidi (Janssen Research & Development) ;
Gold, Stefan M. (University Medical Center Hamburg-Eppendorf) ;
Hoogendijk, Witte J. G. (Erasmus University Medical Centre) ;
Mondragón, Valeria Jordán (Medical Director Neuroscience for Region Europe at Novartis Pharma) ;
Maron, Eduard (West Tallinn Central Hospital) ;
Martynowicz, Jadwiga (Janssen Research & Development) ;
Melloni, Elisa (IRCCS Scientific Institute Ospedale San Raffaele) ;
Otte, Christian (Charité - Universitätsmedizin Berlin) ;
Perez-Fuentes, Gabriela (Hospital Universitari Vall d'Hebron) ;
Poletti, Sara (IRCCS Scientific Institute Ospedale San Raffaele) ;
Schmidt, Mark E. (Janssen Pharmaceutica NV) ;
van de Ketterij, Edwin (European Infrastructure for Translational Medicine (EATRIS)) ;
Woo, Katherine (Janssen Research & Development) ;
Flossbach, Yanina (Novartis Pharma AG) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Savitz, Adam J. (Department of Neuroscience) ;
Pariante, Carmine M (National Institute for Health Research Mental Health Biomedical Research Centre) ;
Universitat Autònoma de Barcelona
Criteria for treatment-resistant depression (TRD) and partially responsive depression (PRD) as subtypes of major depressive disorder (MDD) are not unequivocally defined. In the present document we used a Delphi-method-based consensus approach to define TRD and PRD and to serve as operational criteria for future clinical studies, especially if conducted for regulatory purposes. [...]
2021 - 10.1038/s41380-021-01381-x
Molecular psychiatry, Vol. 27 (december 2021) , p. 1286-1299
|
|
|
10.
|
|
15 p, 471.4 KB |
Prodromal phase : Differences in prodromal symptoms, risk factors and markers of vulnerability in first episode mania versus first episode psychosis with onset in late adolescence or adulthood
/
Verdolini, Norma (Hospital Clínic i Provincial de Barcelona) ;
Borràs, Roger (Hospital Clínic i Provincial de Barcelona) ;
Sparacino, Giulio (Hospital Clínic i Provincial de Barcelona) ;
Garriga, Marina (Hospital Clínic i Provincial de Barcelona) ;
Sagué-Vilavella, Maria (Hospital Clínic i Provincial de Barcelona) ;
Madero, Santiago (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Palacios-Garrán, Roberto (Hospital Clínic i Provincial de Barcelona) ;
Serra, Maria (Hospital Clínic i Provincial de Barcelona) ;
Forte, Maria Florencia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Salagre, Estela (Hospital Clínic i Provincial de Barcelona) ;
Aedo, Alberto (Hospital Clínic i Provincial de Barcelona) ;
Salgado-Pineda, Pilar (FIDMAG Germanes Hospitalàries Research Foundation) ;
Salvatierra, Irene Montoro (Universitat Rovira i Virgili) ;
Sánchez Gistau, Vanessa (Universitat Rovira i Virgili) ;
Pomarol-Clotet, Edith (FIDMAG Germanes Hospitalàries Research Foundation) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Carvalho, André F (Deakin University) ;
Garcia Rizo, Clemente (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Undurraga, Juan (Instituto Psiquiátrico Dr. J. Horwitz Barak) ;
Reinares, María (Hospital Clínic i Provincial de Barcelona) ;
Martínez-Àran, Anabel (Hospital Clínic i Provincial de Barcelona) ;
Bernardo, Miquel (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Vieta, Eduard (Hospital Clínic i Provincial de Barcelona) ;
Pacchiarotti, Isabella (Hospital Clínic i Provincial de Barcelona) ;
Amoretti, Silvia (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
This study was aimed at identifying differences in the prodromal symptoms and their duration, risk factors and markers of vulnerability in patients presenting a first episode mania (FEM) or psychosis (FEP) with onset in late adolescence or adulthood in order to guide tailored treatment strategies. [...]
2022 - 10.1111/acps.13415
Acta psychiatrica Scandinavica, Vol. 146 (february 2022) , p. 36-50
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
